MSD and Gilead Announce Promising Results for Once-Weekly HIV Treatment in Phase 2 Study

Gilead Sciences, Inc. (Nasdaq: GILD) and Merck (NYSE: MRK), known as MSD outside of the United States and Canada, announced new results from a Phase 2 clin...

October 21, 2024 | Monday | News
Sanofi Partners with Orano Med to Pioneer Next-Generation Radioligand Therapies for Rare Cancers

  Sanofi and Orano Med, a subsidiary of the Orano Group and a pioneer in the development of targeted alphatherapies in oncology, have entered into ...

October 17, 2024 | Thursday | News
Avirmax Biopharma to Showcase Innovative Gene Therapy Advances at AAO 2024

Avirmax Biopharma Inc. (ABI) team will attend AAO 2024, the American Academy of Ophthalmology's annual meeting in Chicago, October 17-21, 20...

October 16, 2024 | Wednesday | News
Andelyn Biosciences Partners with Hubble Therapeutics to Advance Gene Therapy for Rare Childhood Blindness

 Andelyn Biosciences, Inc., a leading and patient-focused cell and gene therapy Contract Development and Manufacturing Organization (CDMO), has been s...

October 11, 2024 | Friday | News
PROCEPT BioRobotics Launches FDA-Approved Trial Comparing Aquablation to Prostatectomy for Cancer Treatment

A Prospective, Randomized, Multicenter Study Assessing the Safety and Efficacy of Aquablation Therapy in Men with Grade Group 1 to 3 Localized Prostate C...

October 08, 2024 | Tuesday | News
Enara Bio Secures $32.5 Million in Series B Financing, Co-Led by Pfizer Ventures and M Ventures

New investors Pfizer Ventures and M Ventures co-led the financing, with participation from all existing investors including RA Capital, Samsara BioCapi...

October 03, 2024 | Thursday | News
Kailera Therapeutics Launches with Ambitious Plans for GLP-1 Drugs Targeting Obesity and Metabolic Conditions

In a year when metabolic diseases have drawn major investor interest, the newest player has big-name backing, a sizable war chest and veteran leadership. ...

October 02, 2024 | Wednesday | News
Thryv Therapeutics Secures FDA Orphan Drug Designation for LQT-1213 to Treat Long QT Syndrome

Thryv Therapeutics, a clinical stage biotech company dedicated to developing treatments for rare and life-threatening cardiovascular indications, announced...

October 02, 2024 | Wednesday | News
Alora Pharmaceuticals Champions ADHD Awareness Month: Empowering the ADHD Community

This ADHD Awareness Month, we stand with the ADHD community. Alora Pharmaceuticals, LLC, the largest U.S. manufacturer of methylphenidate medications,...

October 02, 2024 | Wednesday | News
European Commission Approves Junshi Biosciences' Toripalimab for Two Key Cancer Indications

Shanghai Junshi Biosciences , a leading innovation-driven biopharmaceutical company dedicated to the discovery, development, and commercialization of nov...

September 25, 2024 | Wednesday | News
Genespire Secures €46.6M Series B to Propel First Pediatric Gene Therapy into Clinical Trials

Genespire raises €46.6 million (~$52 million) in a Series B round to advance its first pediatric in-vivo gene therapy into the clinic One of the la...

September 25, 2024 | Wednesday | News
Takeda Receives Japanese Approval for FRUZAQLA® (Fruquintinib) in Metastatic Colorectal Cancer Treatment

— Approval based on results from global Phase III FRESCO-2 trial in patients with previously treated metastatic colorectal cancer — &md...

September 24, 2024 | Tuesday | News
Nicox’s ZERVIATE® Approved for Ocular Itching in China, Set to Launch with Ocumension Therapeutics

Nicox’s partner, Ocumension Therapeutics, has received approval for ZERVIATE® for ocular itching in China ZERVIATE® launch in China wil...

September 18, 2024 | Wednesday | News
Nuance Pharma Expands Bentrio® Nasal Spray Reach Across East and South East Asia

Altamira Therapeutics announces the extension of its exclusive license with Nuance Pharma to cover Singapore, Malaysia, Thailand, Philippines, Indonesia,...

September 17, 2024 | Tuesday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2025 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close